Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Grading of prostatic carcinoma.

× No keyword cloud information.

16 in total

1. Nuclear protein as a prognostic factor of growth activity in prostatic adenocarcinoma.

Authors: G R Dohle; J A Beekhuis; G J van Steenbrugge; F H Schröder; H J Tanke
Journal: Urol Res Date: 1996

2. Shift of tumor features in patients with clinically localized prostate cancer undergoing radical prostatectomy since the beginning of the PSA era.

Authors: Herbert Augustin; Marco Auprich; Philipp Stummvoll; Katja Lipsky; Karl Pummer; Peter Petritsch
Journal: Wien Klin Wochenschr Date: 2006-06 Impact factor: 1.704

3. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.

Authors: M P Gallee; E Visser-de Jong; J A van der Korput; T H van der Kwast; F J ten Kate; F H Schroeder; J Trapman
Journal: Urol Res Date: 1990

4. High-dose-rate brachytherapy combined with long-term hormonal therapy for high-risk prostate cancer: results of a retrospective analysis.

Authors: Ryoong-Jin Oh; Yasuo Yoshioka; Eiichi Tanaka; Hiroya Shiomi; Iori Sumida; Fumiaki Isohashi; Osamu Suzuki; Koji Konishi; Yoshifumi Kawaguchi; Satoaki Nakamura; Masahiro Kato; Takehiro Inoue
Journal: Radiat Med Date: 2006-01

5. The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer.

Authors: M Rudoni; G Antonini; M Favro; A Baroli; M Brambilla; G Cardani; L Ciardi; G M Sacchetti; E Inglese
Journal: Eur J Nucl Med Date: 1995-03

Review 6. Reproducibility and reliability of tumor grading in urological neoplasms.

Authors: Rainer Engers
Journal: World J Urol Date: 2007-09-09 Impact factor: 4.226

7. Histologic grading of prostatic adenocarcinoma: intraobserver reproducibility of the Mostofi, Gleason and Böcking grading systems.

Authors: M L Cintra; A Billis
Journal: Int Urol Nephrol Date: 1991 Impact factor: 2.370

8. The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin.

Authors: L Jeromin
Journal: Int Urol Nephrol Date: 1982 Impact factor: 2.370

9. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.

Authors: N Konishi; Y Hiasa; H Matsuda; M Tao; T Tsuzuki; I Hayashi; Y Kitahori; T Shiraishi; R Yatani; J Shimazaki
Journal: Am J Pathol Date: 1995-10 Impact factor: 4.307

10. Cell kinetic and cytological grading of prostatic carcinoma.

Authors: B Helpap
Journal: Virchows Arch A Pathol Anat Histol Date: 1981